Lp-PLA2 Selective Inhibitor (Darapladib) Effect In Lowering The Expression Level Of IL-1B And IL-6 In The Renal At Type 2 Diabetes Mellitus
Titin Andri Wihastuti,1 Fitria Nugraha Aini,2,3 Cholid Tri Tjahjono,4 Yuni Hendrati Sulfia,3 Zuhrotus Sholichah,3 Teuku Heriansyah5 1Department of Basic Science in Nursing, Faculty of Medicine, University of Brawijaya, Malang, East Java, Indonesia; 2Faculty of Medicine, University of Islam Malang, M...
Main Authors: | Wihastuti TA, Aini FN, Tjahjono CT, Sulfia YH, Sholichah Z, Heriansyah T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/lp-pla2-selective-inhibitor-darapladib-effect-in-lowering-the-expressi-peer-reviewed-article-VHRM |
Similar Items
-
Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model
by: Wihastuti Titin Andri, et al.
Published: (2018-04-01) -
Elaborate evaluation of serum and tissue oxidized LDL level with darapladib therapy: A feasible diagnostic marker for early atherogenesis
by: Teuku Heriansyah, et al.
Published: (2017-02-01) -
IL-18 gene polymorphism in type I diabetic patients: a case-control study
by: Massoud A, et al.
Published: (2009-04-01) -
IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases
by: Yasutaka Mitamura, et al.
Published: (2020-07-01) -
Additive or Synergistic Interactions Between IL-17A or IL-17F and TNF or IL-1β Depend on the Cell Type
by: Mélissa Noack, et al.
Published: (2019-07-01)